14307-33-6[Ca+2].[O]=[Cr](=[O])([O-])[O][Cr](=[O])(=[O])[O-]RMISVBXFFXBNAD-UHFFFAOYSA-N14307-33-6DTXSID7051719Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302 (97.8%): Harmful if swallowed [Warning Acute toxicity, oral]
P203, P261, P264, P270, P272, P273, P280, P301+P317, P302+P352, P318, P321, P330, P333+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 93 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H301: Toxic if swallowed [Danger Acute toxicity, oral]
Chemical: Chromic acid (H2Cr2O7), calcium salt (1:1)
Chromic acid (H2Cr2O7), calcium salt (1:1): Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
CrVI compounds are irritants, sensitizers, and may be corrosive to the skin. CrVI compounds are respiratory tract irritants and may cause pulmonary sensitization. CrVI may cause acute tubular necrosis and liver injury. [ATSDR Case Studies] Readily forms hydrates: hexahydrate at <10 deg C, pentahydrate at 20-40 deg C, pentahydrate at 50-60 deg C, and the monohydrate at >70 deg C; [Ullmann] See Chromium and linked occupational diseases.
Acute Tox. 4 (97.8%)
Acute toxicity - category 2
0.0002 [mg/m3], as Cr(VI), inhalable particulate matter
0.0005 [mg/m3], as Cr(VI), inhalable particulate matter
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…